Posts Tagged ‘RNA’

Genome packaging in influenza virus

Wednesday, February 17th, 2010

RNP Influenza A virus is the prototype of the Orthomyxoviridae, and like all members of this family, the negative-sense RNA that comprises its genome is divided into separate segments. These vRNA segments share a common organisation; a long central coding region (in antisense), sometimes encoding more than one polypeptide, flanked by relatively short untranslated regions (UTRs) and at the termini, sequences conserved between segments that show partial complementarity. The vRNA segments are separately encapsidated into ribonucleoprotein (RNP) structures by viral polypeptides. These RNPs act as independent units for the purposes of viral RNA synthesis, which occurs in the nuclei of infected cells. Replicated vRNAs are exported (as RNPs) from the nucleus via the cellular CRM1 pathway, and at the final stage of viral assembly, are incorporated into the virion as it buds from the apical plasma membrane of the cell. The process of virion assembly is not well understood but is thought to involve a series of protein-protein interactions between the cytoplasmic tails of the viral integral membrane proteins, the matrix protein and the RNPs.

Genome segmentation confers evolutionary advantages on influenza viruses, but also poses a problem in virion assembly. The eight segments encode 12 identified polypeptides. At least one copy of each of the eight vRNAs must be packaged for a single virion to be able to initiate a productive infection. Until recently, the process by which this was achieved was poorly understood, but a clearer picture has begun to emerge of a mechanism for specifically packaging a full genome, mediated by cis-acting packaging signals in the vRNAs. This review aims to summarise the thought processes and experimental evidence leading up to the currently accepted model for influenza A genome packaging and to highlight the main questions remaining.

Genome packaging in influenza A virus. J Gen Virol. Dec 2 2009

Related:

Expression strategies of ambisense viruses

Monday, February 8th, 2010

Among the negative RNA viruses, ambisense RNA viruses occupy a distinct niche. Ambisense viruses contain at least one ambisense RNA segment, i.e. an RNA that is in part of positive and in part of negative polarity. Because of this unique gene organization, one might expect ambisense RNA viruses to borrow expression strategies from both positive and negative RNA viruses. However, they have little in common with positive RNA viruses, but possess many features of negative RNA viruses. Transcription and/or replication of their RNAs appear generally to be coupled to translation. Such coupling might be important to ensure temporal control of gene expression, allowing the two genes of an ambisense RNA segment to be differently regulated. Ambisense viruses can infect one host asymptomatically and in certain cases, they can lethally infect two hosts of a different kingdom. A possible model to explain the differential behavior of a given virus in different hosts could be that perturbation of the translation machinery would lead to differences in the severity of symptoms.

Ambisense

The ambisense coding strategy is an unusual way of encoding genes that presumably allows the virus to temporally control expression of the viral proteins, in particular if coupling of translation to transcription enhances the level of vc-encoded versus v-encoded protein expression. In any event, translation itself and/or translational control appear to play an important role in regulation of gene expression of ambisense viruses. Ambisense viruses have two hosts in which they can replicate. In their vector or reservoir host, infection is usually asymptomatic. However, in another host, multiplication of the virus can be lethal. Replication/transcription experiments in different host cell types would be helpful to shed further light on the differences observed in different hosts. At present, there are many complementary ways to study ambisense virus replication/ transcription such as cell culture, in vitro assays and reverse genetics systems. Since ambisense viruses are the meeting point of different viral families and are able to replicate in different hosts whether plants or animals and have different behaviors depending on the host, it would be particularly important to better understand the complex replicative cycle of ambisense viruses, in order to find the means to alleviate the lethal aspects of these pathogens.

Expression strategies of ambisense viruses. Virus Research 93: 141-150, 2003. doi: 10.1016/S0168-1702(03)00094-7

Related:

HIV-1 Genomic RNA Trafficking

Wednesday, October 21st, 2009

HIV-infected cell Retroviruses package two copies of full-length RNA in one virus particle (virion). One of the consequences of packaging two RNAs is frequent recombination during DNA synthesis when reverse transcriptase uses parts of both RNAs as templates. Although frequent recombination can occur during DNA synthesis of all virions, a genotypically different recombinant can only be generated from virions that package two different RNAs (heterozygous virions). High genetic diversity of HIV-1 presents a difficult barrier for drug treatment and vaccine development.

Using a recombination assay, researchers have shown that RNA molecules derived from two similar HIV-1 proviruses can randomly assort and be efficiently copackaged into virions. However, heterozygous virions are formed less efficiently when the two proviruses contain variations in their dimerization initiation signal (DIS). Located at the loop of stem-loop 1 of the 5′ untranslated region, the DIS is a 6-nt palindromic sequence that forms the initial interaction between the two HIV-1 RNAs. The Gag polyproteins of HIV-1 interact with, and specifically package, the viral RNA to generate infectious viruses. We have previously examined whether RNA dimerization occurs prior to virus assembly using HIV-1 variants with DIS mutations that abolish their palindromic nature (for example, from GCGCGC to GGGGGG) but can form perfect base pairs with the DIS of a partner virus (such as a virus with CCCCCC at the DIS). In the coinfected cells if dimeric RNAs are packaged, then the GGGGGG viral RNA would preferentially pair with CCCCCC viral RNA, and an increase in the formation of heterozygous virions would be observed. In contrast, if two monomeric RNAs are packaged, then there would not be an increase in heterozygous viruses. Results reveal that most of the virions from coinfected cells were heterozygous, indicating that copackaged RNA partner selection, i.e. dimerization, occurs prior to the packaging of virion RNA.

HIV-1 full-length RNAs serve at least two functions: as a template for Gag/Gag-Pol translation, and as genetic material packaged in the virion. Many cellular factors ensure the correct macromolecular trafficking between nucleus and cytoplasm; specifically, mechanisms exist to prevent the export of intron-containing transcripts, such as the full-length HIV-1 RNA. Most cellular mRNAs are fully spliced before export and many are believed to exit the nucleus via the NXF1-dependent pathway. However, many proteins and some RNAs use an alternative, CRM-1-dependent pathway to migrate out of the nucleus. The extent to which these two pathways are linked or overlap is currently unknown, and the reason for their differential use is subject to speculation.

Once transcribed, the nascent full-length RNA of HIV-1 must travel to the appropriate host cell sites to be translated or to find a partner RNA for copackaging to form newly generated viruses. In this report, scientists sought to identify the location where HIV-1 RNA initiates dimerization and the influence of the RNA transport pathway used by the virus on downstream events essential to viral replication. Using a cell-fusion-dependent recombination assay, they were able to demonstrate that the two RNAs destined for copackaging into the same virion select each other mostly within the cytoplasm. Moreover, by manipulating the RNA export element in the viral genome, they showed that the export pathway taken is important for the ability of RNA molecules derived from two viruses to interact and be copackaged. These results further illustrate that at the point of dimerization the two main cellular export pathways are partially distinct. Lastly, by providing Gag in trans, they demonstrated that Gag is able to package RNA from either export pathway, irrespective of the transport pathway used by the gag mRNA. These findings provide unique insights into the process of RNA export in general, and more specifically, of HIV-1 genomic RNA trafficking.

Probing the HIV-1 Genomic RNA Trafficking Pathway and Dimerization by Genetic Recombination and Single Virion Analyses. 2009 PLoS Pathog 5(10): e1000627 doi:10.1371/journal.ppat.1000627

Related:

Does the outcome of HCV infection vary with the infecting virus type?

Wednesday, September 26th, 2007

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease that can lead to appreciable morbidity including cirrhosis and hepatocellular carcinoma (HCC). HCV can be classified into several genotypes based on variations in the nucleotide sequence of its genome. The infecting HCV type has been shown to be clinically important because it predicts response to antiviral therapy, with infection by type 1 being associated with the most resistance to treatment. There is no consensus as to whether differences in the clinical and histological severity of liver disease can be explained by differences in the infecting type. Several studies suggest genotype 1b to be associated with more severe disease, but most have found little or no influence of genotype on disease progression. Similar ambiguity surrounds the study of the role of HCV genotypes in spontaneous viral clearance. Some studies have found no association between the viral type and the spontaneous clearance of HCV RNA, with host factors like sex seeming to be more important, while other studies have suggested that infection by genotype 1 or 1b might be less likely to clear spontaneously when compared with infection by other genotypes.
The aim of this study was to investigate whether the HCV type might influence the clinical outcome of infection. Study serum samples were assembled from 749 individuals enrolled into the UK HCV National Register from which data on clinical outcomes were determined. The prevalence of HCV type 1 among those who cleared infection was 69% and among those who remained HCV RNA positive was 51%: type 1 infections were more likely to be HCV RNA negative than non-1 types. Type 1 infections were also more likely to be associated with histological stage scores above the median when compared with non-1 types. In conclusion, HCV type 1 infection was more often HCV RNA negative, suggesting that spontaneous clearance may occur more commonly with this type. Among the RNA-positive infections, type 1 infection may be more aggressive than types 2/3.

Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?
J Viral Hepat. 2007 14: 213-220